ZA935831B - Methods of treating psoriasis employing substituted azaspiranes - Google Patents
Methods of treating psoriasis employing substituted azaspiranesInfo
- Publication number
- ZA935831B ZA935831B ZA935831A ZA935831A ZA935831B ZA 935831 B ZA935831 B ZA 935831B ZA 935831 A ZA935831 A ZA 935831A ZA 935831 A ZA935831 A ZA 935831A ZA 935831 B ZA935831 B ZA 935831B
- Authority
- ZA
- South Africa
- Prior art keywords
- methods
- treating psoriasis
- azaspiranes
- employing substituted
- employing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929217116A GB9217116D0 (en) | 1992-08-13 | 1992-08-13 | Methods |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA935831B true ZA935831B (en) | 1995-01-18 |
Family
ID=10720232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA935831A ZA935831B (en) | 1992-08-13 | 1993-08-11 | Methods of treating psoriasis employing substituted azaspiranes |
Country Status (12)
Country | Link |
---|---|
US (1) | US5981538A (zh) |
EP (1) | EP0654996A4 (zh) |
JP (1) | JPH08500120A (zh) |
KR (1) | KR950702830A (zh) |
CN (1) | CN1037815C (zh) |
AU (1) | AU670970B2 (zh) |
CA (1) | CA2142223A1 (zh) |
GB (1) | GB9217116D0 (zh) |
MX (1) | MX9304878A (zh) |
NZ (1) | NZ255753A (zh) |
WO (1) | WO1994004150A1 (zh) |
ZA (1) | ZA935831B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9217121D0 (en) * | 1992-08-13 | 1992-09-23 | Smithkline Beecham Corp | Methods |
NZ286951A (en) * | 1995-07-13 | 1998-02-26 | Anormed Inc Substituted Under | N-n-diethyl-8,8-dipropyl-2-azaspiro[4,5]decane-2-propanamine dimaleate |
BR9601909A (pt) * | 1995-07-13 | 1999-10-13 | Smithkline Beecham Corp | N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato |
US5843936A (en) * | 1996-06-28 | 1998-12-01 | Bernstein; Lawrence R. | Topical administration of azaspiranes to prevent or treat skin conditions associated with hyperproliferation of keratinocytes |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4963557A (en) * | 1987-09-28 | 1990-10-16 | Smithkline Beecham Corporation | Immunomodulatory azaspiranes |
US5064835A (en) * | 1990-03-01 | 1991-11-12 | Merck & Co., Inc. | Hydroxymacrolide derivatives having immunosuppressive activity |
ES2118087T3 (es) * | 1990-08-10 | 1998-09-16 | Anormed Inc | Composiciones inmunosupresoras. |
WO1992004899A1 (en) * | 1990-09-24 | 1992-04-02 | Smithkline Beecham Corporation | Methods |
-
1992
- 1992-08-13 GB GB929217116A patent/GB9217116D0/en active Pending
-
1993
- 1993-08-11 MX MX9304878A patent/MX9304878A/es not_active IP Right Cessation
- 1993-08-11 ZA ZA935831A patent/ZA935831B/xx unknown
- 1993-08-12 WO PCT/US1993/007632 patent/WO1994004150A1/en not_active Application Discontinuation
- 1993-08-12 EP EP93920038A patent/EP0654996A4/en not_active Withdrawn
- 1993-08-12 AU AU50101/93A patent/AU670970B2/en not_active Ceased
- 1993-08-12 CA CA002142223A patent/CA2142223A1/en not_active Abandoned
- 1993-08-12 KR KR1019950700495A patent/KR950702830A/ko not_active Application Discontinuation
- 1993-08-12 JP JP6506427A patent/JPH08500120A/ja active Pending
- 1993-08-12 NZ NZ255753A patent/NZ255753A/xx unknown
- 1993-08-13 CN CN93116402A patent/CN1037815C/zh not_active Expired - Fee Related
-
1997
- 1997-01-29 US US08/792,691 patent/US5981538A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
MX9304878A (es) | 1994-05-31 |
KR950702830A (ko) | 1995-08-23 |
AU5010193A (en) | 1994-03-15 |
GB9217116D0 (en) | 1992-09-23 |
CN1037815C (zh) | 1998-03-25 |
EP0654996A1 (en) | 1995-05-31 |
WO1994004150A1 (en) | 1994-03-03 |
EP0654996A4 (en) | 1997-09-17 |
JPH08500120A (ja) | 1996-01-09 |
CA2142223A1 (en) | 1994-03-03 |
AU670970B2 (en) | 1996-08-08 |
NZ255753A (en) | 1999-06-29 |
US5981538A (en) | 1999-11-09 |
CN1100932A (zh) | 1995-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA945545B (en) | Psoriasis treatment | |
GB9119557D0 (en) | Method of treating hair | |
GB2269164B (en) | Treatment of polyvinylchloride | |
GB2271579B (en) | Treatment of wood | |
AU3973793A (en) | Method of treating cancer | |
GB9218027D0 (en) | Novel method of treatment | |
ZA935831B (en) | Methods of treating psoriasis employing substituted azaspiranes | |
GB2283485B (en) | Treatment of sludge | |
GB9217998D0 (en) | Methods of treating cancer | |
GB9202196D0 (en) | Method of treatment | |
GB9226309D0 (en) | Improved method of manufacture | |
HU905312D0 (en) | Preparation for the treating of psoriasis topicalis | |
GB9218597D0 (en) | Novel method of treatment | |
ZA93491B (en) | Treatment of psychoses | |
GB9201391D0 (en) | Method of treatment | |
BG98118A (en) | Methods of psoriasis treatment | |
ZA932731B (en) | Method of treating gar-transformylase-dependent tumors | |
RU1833736C (en) | Means of treatment of psoriasis | |
EP0654997A4 (en) | COMPOSITIONS OF SUBSTITUTED AZASPIRANS AND METHOD FOR TREATING PSORIASIS THEREFOR. | |
GB9226371D0 (en) | Novel method of treatment | |
GB9202020D0 (en) | Method of treatment | |
GB9218188D0 (en) | Method of treatment | |
GB9207275D0 (en) | Method of treatment | |
GB9226252D0 (en) | Method of treatment | |
GB9223252D0 (en) | Method of treatment |